Berlin – Schnittker Möllmann Partners (SMP) advised DEMECAN, a producer and wholesaler of medical cannabis, on its Series A financing round. In the context of the financing round with a total volume of 7 million euros, the Private Investor Network of btov Partners and a German Single Family Office invested equal shares in the cannabis company. The company says, it is planning to use the fresh funds for further expansion of its production facilities and wholesale activities. DEMECAN received comprehensive legal advice from a team led by SMP partners Martin Schaper and Benjamin Ullrich.
